Monoclonal antibody therapy
World
COVID-19: Is monoclonal antibody therapy really feasible?

In this interview with NewsClick, Dr. Satyajit Rath talks about the limitations of monoclonal antibody therapy


    All text content published on peoplesdispatch.org is the property of Peoples Dispatch and is under a Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA) license.
    For license to republish any audio, video or image content, please get in touch with the Peoples Dispatch Team.
    Share on Facebook Share
    Share on Twitter Tweet
    Share on Reddit Share
    Share on Whatsapp Share
    Send email Mail
    Print this Print